- Home
- GWH vs PRPH Comparison
GWH vs PRPH Comparison
Compare GWH & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- PRPH
- Stock Information
- Founded
- GWH 2011
- PRPH 1989
- Country
- GWH United States
- PRPH United States
- Employees
- GWH N/A
- PRPH N/A
- Industry
- GWH Industrial Machinery/Components
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- GWH Miscellaneous
- PRPH Health Care
- Exchange
- GWH Nasdaq
- PRPH Nasdaq
- Market Cap
- GWH 17.1M
- PRPH 15.2M
- IPO Year
- GWH N/A
- PRPH 1997
- Fundamental
- Price
- GWH $1.33
- PRPH $0.38
- Analyst Decision
- GWH Hold
- PRPH
- Analyst Count
- GWH 5
- PRPH 0
- Target Price
- GWH $2.10
- PRPH N/A
- AVG Volume (30 Days)
- GWH 303.0K
- PRPH 4.1M
- Earning Date
- GWH 08-13-2025
- PRPH 08-13-2025
- Dividend Yield
- GWH N/A
- PRPH N/A
- EPS Growth
- GWH N/A
- PRPH N/A
- EPS
- GWH N/A
- PRPH N/A
- Revenue
- GWH $4,155,999.00
- PRPH $5,845,000.00
- Revenue This Year
- GWH $179.38
- PRPH $221.82
- Revenue Next Year
- GWH $175.77
- PRPH N/A
- P/E Ratio
- GWH N/A
- PRPH N/A
- Revenue Growth
- GWH N/A
- PRPH N/A
- 52 Week Low
- GWH $0.76
- PRPH $0.22
- 52 Week High
- GWH $14.10
- PRPH $4.19
- Technical
- Relative Strength Index (RSI)
- GWH 48.56
- PRPH 57.67
- Support Level
- GWH $0.95
- PRPH $0.32
- Resistance Level
- GWH $1.44
- PRPH $0.41
- Average True Range (ATR)
- GWH 0.13
- PRPH 0.03
- MACD
- GWH 0.07
- PRPH 0.00
- Stochastic Oscillator
- GWH 76.53
- PRPH 68.89
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.